St. Jude Medical Inc. (“St. Jude”), which was acquired by Abbott Laboratories in 2017, entered into a settlement last week with the United States Department of Justice (“DOJ”) for $27 million to resolve allegations it had...more
7/16/2021
/ Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Food and Drug Administration (FDA) ,
Fraud ,
Manufacturers ,
Manufacturing Defects ,
Medicaid ,
Medical Devices ,
Medicare ,
Settlement ,
TRICARE ,
Whistleblowers
The False Claims Act (“FCA”), especially its qui tam component, has repeatedly proven to be the most effective weapon the federal government can employ to recover payments private citizens and entities fraudulently obtain. ...more
5/4/2021
/ Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Federal Funding ,
Federal Grants ,
Fraud ,
Infectious Diseases ,
Personal Protective Equipment ,
Qui Tam ,
Relators ,
Whistleblowers